Walgreens Co: (NYSE: WAG)

$50.90

0.52 (1.03%)

Volume 3,545,429

Jun 18 04:02 PM ET

Zacks Rank: 3-Hold

Zacks Rank	Definition	Annualized Return
#1	Strong Buy	26.6%
#2	Buy	18.71%
#3	Hold	10.12%
#4	Sell	4.32%
#5	Strong Sell	2.16%
S&P	500	9.93%

Overview Quote

            Stock Activity
        
		Day Low - High
		50.16 - 51.10
	
		52wk Low - High
		28.53 - 51.25
	
		Previous Close
		50.38
	
		Avg. Volume
		4,761,489
	
		Industry
		RETAIL-DRUG STR
	
		Market Cap
		47.73 B
	
		Div - Yield
		1.10 - 2.18
	
		Beta
		1.07
	
		P/E (F1)
		15.43
	
		Current Year Est.
		3.27
	
		Quarterly Earnings ESP 
		0.00%
	
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

                Premium research
            
		Zacks Rank  Short-Term: 1-3 Months
                                                                
                                                                Zacks #1 Rank Strong Buys
                                                                
                                                            This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below. 

                                                                        Zacks Rank
                                                                        Definition
                                                                        Annualized Return
                                                                    
                                                                        #1
                                                                        Strong Buy
                                                                        26.6%
                                                                    
                                                                        #2
                                                                        Buy
                                                                        18.71%
                                                                    
                                                                        #3
                                                                        Hold
                                                                        10.12%
                                                                    
                                                                        #4
                                                                        Sell
                                                                        4.32%
                                                                    
                                                                        #5
                                                                        Strong Sell
                                                                        2.16%
                                                                    
                                                                        S&P
                                                                        500
                                                                        9.93%
                                                                    
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank
                                                        
		3
Hold

		Zacks Recommendation  Long-Term: 6+ Months
                                                                
                                                                All Outperform Rated Stocks
                                                                
                                                            Zacks Recommendations are an excellent predictor of stock price movement over a 6+ month time frame. The recommendations come from the Zacks Equity Research group which combines the Zacks Rank with the insights from their team of over 50 equity analysts. The result is superior long term stock ratings.
The Zacks Recommendations are split into 3 groups: Buy, Hold and Sell. Our Buy recommendations have generated returns of 34.4% in 2006, and 16.69% in 2007. When Zacks Premium members click on the recommendation it will launch them to the Zacks Equity Research report for the stock.    More on these reports below.

                                                                    Difference Between Zacks Rank and Zacks Recommendation

                                                                    Zacks Equity Research Home
Zacks Premium - The only way to get access to Zacks Recommendations
                                                                
		Neutral
	
		Zacks Industry Rank Which industries are set to outperform or underperform the market? You'll find the answer here. We have broken down all industries into over 200 classifications. Then ranked these industries using the most powerful indicator we know (the Zacks Rank). The higher the industry rank, the better the industry should perform in the future. Once you have found an attractive industry then check out the Rank in Industry to find the best stocks within the industry.
When Zacks Premium members click on the Zacks Industry Rank link they will see the full listing of industries and their current rankings.

                                                                About Zacks Industry Rank

                                                                Zacks Industry Rank - All current industry ranks. 

                                                                Zacks Premium - The only way to get access to the Zacks Industry Rank
                                                            
		104 out of 265
	
		Equity Research Report The Zacks Recommendations and Zacks Target Prices are just two of the valuable resources you'll find in the reports created by the Zacks Equity Research group. When Zacks Premium members click on this link they will taken to a page that gives them access to the Zacks Equity Research report for the stock.

                                        Zacks Equity Research Home
                                        Zacks Premium - The only way to get access to Zacks Recommendations
                                    
Updated as of 04/17/2013

		PREMIUM
	
    (  = Change in last 30 days) 
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial 
Zacks Premium Home | Zacks Rank Stock Education

                Key Earnings Data
            
                            P/E (F1)
                            15.43
                        
                            PEG Ratio
                            1.24
                        
                            Current Year Est.
                            3.27
                        
                            Current Quarter Estimate
                            0.90
                        
                            Most Accurate Estimate
                            0.90
                        
                            Earnings ESP 
                            0.00%
                        
                            Next Earnings Report Date
                            06-25-2013
                        
                            EPS Last Year
                            2.69
                        
                            Expected Earnings Growth
                            12.43%
                        
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

            Company Description
        
Walgreen Co. is a national retail pharmacy chain and considered the leader in innovative drugstore retailing. Walgreens pioneered many store features that are becoming standards in the industry. Among those concepts are: Computerized pharmacies, Point-of-sale scanning, Freestanding stores with drive-thru pharmacies, and Intercom Plus, Walgreens advanced new pharmacy computer and workflow system. Intercom Plus allows pharmacists to spend more time counseling patients by assigning administrative tasks to pharmacy technicians   
Full WAG Company Report

 Analyst Report on WAG

NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.

            Interactive Java Charting | Fundamental Charts
        
            <a href="#"><img id="dart_image_1" src="http://b7d61a7c6b8c307bf531-a92a66b9587e2a0aa805bd4e70b98407.r95.cf2.rackcdn.com/images/zacks/logos/zacks_logo_230x76.png" width="336" height="280" border="0" alt="" /></a>        
Turn Earnings Surprises into quick profits.
 
WAG Chart  by YCharts

Earnings Estimates

	Current Qtr (05/2013)	Next Qtr (08/2013)	Current Year (08/2013)	Next Year (08/2014)
Average Estimate	0.90	0.82	3.27	3.64
Number of Estimates	12	12	12	14
Low Estimate	0.79	0.75	3.17	3.08
High Estimate	0.95	0.91	3.35	NA
Year Ago EPS	0.62	0.53	2.71	3.27
EPS Growth	44.62%	53.93%	20.51%	11.52%

More WAG Estimates

Average Earnings Estimates for WAG

EPS Growth for WAG

Industry Analysis

Name	Symbol	Previous Close
WALGREEN CO	WAG	50.38
GNC HOLDINGS	GNC	46.88
HERBALIFE LTD	HLF	48.90
RITE AID CORP	RAD	3.14
AMERISOURCEBRGN	ABC	55.66
CARDINAL HEALTH	CAH	48.25
CVS CAREMARK CP	CVS	59.27
MCKESSON CORP	MCK	114.38
PHARMERICA CORP	PMC	15.83
BIOSCRIP INC	BIOS	15.79

Sector:Retail-Wholesale>> Industry:RETAIL-DRUG STR

COMPARE TICKER vs. Its Peers

Zacks Commentary

WAG-DEA Settlement to Hurt 3Q Earnings

Jun 12, 2013

Rite Aid to Refinance Debt

Jun 10, 2013

Weak May Comps for Rite Aid

Jun 07, 2013

WAG 3Q13 Sales Miss; Strong May

Jun 06, 2013

Still Neutral on CVS Caremark

Jun 05, 2013

Cardinal Stays at Neutral

Jun 04, 2013

Excerpts from Walgreens' Confab

Jun 03, 2013

The Zacks Analyst Blog Highlights: Walgreen, AmerisourceBergen, CVS Caremark, Cardinal Health and R.R. Donnelley & Sons

May 21, 2013

More WAG Zacks Commentary

Financials

EPS TTM	2.69
Sales	71,633
Net Income	2,059
Price/Earnings	18.73
Price/Book	2.51
Price/Cash Flow	13.42
Price/Sales	0.67

More WAG Financials

News

China Nepstar Chain Drugstore is Among the Companies in the Drug Retail Industry With the Lowest Price to Book Ratio (NPD, CVS, WAG) - Financial News Network Online - News Corner

Jun 18, 2013

Is Rite Aid Really Back? - TheMotleyFool

Jun 18, 2013

Is Rite Aid???s Rally Sustainable? - TheMotleyFool

Jun 18, 2013

Next Resistance Level for Walgreen (WAG) is $51.04 - Financial News Network Online - Pivot Alerts

Jun 18, 2013

Walgreen Rises 1.03% on Heavy Volume: Watch For Potential Pullback - Comtex Smartrend(R)

Jun 18, 2013

Walgreen Set to Possibly Pullback After Yesterday's Rally of 1.03% - Comtex Smartrend(R)

Jun 18, 2013

Walgreens Third Quarter 2013 Earnings Release, Conference Call Scheduled for June 25 - Businesswire

Jun 18, 2013

Is This Pharmacy`s Turnaround Done? - TheMotleyFool

Jun 17, 2013

See All News Stories on WAG

Broker Recommendations

Current ABR	1.94
ABR (Last Week)	1.94
# of recs in ABR	17
Average Target Price	49.00
Industry Rank by ABR	104 out of 265
Rank in Industry	4 out of 11

More WAG Broker Recommendations

Day Low - High	50.16 - 51.10
52wk Low - High	28.53 - 51.25
Previous Close	50.38
Avg. Volume	4,761,489
Industry	RETAIL-DRUG STR
Market Cap	47.73 B
Div - Yield	1.10 - 2.18
Beta	1.07
P/E (F1)	15.43
Current Year Est.	3.27
Quarterly Earnings ESP	0.00%

P/E (F1)	15.43
PEG Ratio	1.24
Current Year Est.	3.27
Current Quarter Estimate	0.90
Most Accurate Estimate	0.90
Earnings ESP	0.00%
Next Earnings Report Date	06-25-2013
EPS Last Year	2.69
Expected Earnings Growth	12.43%

Username: Password:

Remember me [?]

Walgreens Co: (NYSE: WAG)

$50.90

0.52 (1.03%)

Volume 3,545,429

Jun 18 04:02 PM ET

Stock Activity

Premium research

Zacks Rank Short-Term: 1-3 Months

Zacks Recommendation Long-Term: 6+ Months

Zacks Industry Rank

Equity Research Report

Key Earnings Data

Company Description

Earnings Estimates

Industry Analysis

Sector:Retail-Wholesale>> Industry:RETAIL-DRUG STR

Zacks Commentary

Financials

News

Broker Recommendations